Pular para o conteúdo
Defeito do septo ventricular
ORPHA:1480CID-10 · Q21.0DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
heart
Também conhecida comoComunicação inter-ventricularVSD
Sinônimos clínicos: Comunicação inter-ventricular

Presença de defeito (abertura) no septo que separa os dois ventrículos do coração. Pode ser congênito ou adquirido.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O **defeito do septo ventricular**, também conhecido popularmente como **comunicação inter-ventricular**, é uma abertura na parede que separa as duas câmaras inferiores do coração. Essa alteração pode fazer com que o sangue flua de forma inadequada, provocando sinais como **sopro cardíaco**, respiração rápida, cansaço e **cianose** (pele ou lábios arroxeados). Em crianças, é frequente que surjam dificuldades alimentares e déficit no ganho de peso e crescimento. No Brasil, a condição não consta na lista de PCDTs de doenças raras do Ministério da Saúde, mas o SUS oferece exames diagnósticos como cariótipo e sequenciamento do exoma, além de atendimento em reabilitação.

📋
Informacoes curadas por IA — podem conter imprecisoes

Presença de defeito (abertura) no septo que separa os dois ventrículos do coração. Pode ser congênito ou adquirido.

Pesquisas ativas
13 ensaios
63 total registrados no ClinicalTrials.gov
Publicações científicas
1 artigos
Último publicado: 2014 Jan-Feb
Medicamentos
12 com registro
PROPRANOLOL, CLORIDRATO DE PROPRANOLOL, SANPRONOL

Tem tratamento?

✓ 12 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
PROPRANOLOLCLORIDRATO DE PROPRANOLOLSANPRONOLTENADRENPROPRANOLOMFURP - PROPRANOLOLIQUEGO - PROPANOLOLPOLOL
Mais 3 moléculas em estudo para esta doença.
🏥
SUS: Cobertura parcialScore: 15%
5 procedimentos SIGTAPCID-10: Q21.0
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (5)
•
Cariótipo — bandas G, Q ou R
•
Pesquisa de microdeleções/microduplicações por FISH
•
Sequenciamento completo do exoma (WES)
•
Dosagem de alfa-fetoproteína
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
10 sintomas
😀
Face
4 sintomas
📏
Crescimento
3 sintomas
👂
Ouvidos
1 sintomas
🦴
Ossos e articulações
1 sintomas
🧠
Neurológico
1 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

—
Fenda submucosa do palato duro
—
Ponte nasal deprimida
—
Fissura palpebral estreita
—
Anormalidade da cartilagem da orelha externa
—
Hipocalcemia
—
Aplasia/Hipoplasia do timo
33sintomas
Sem dados (33)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 33 características clínicas mais associadas, ordenadas por frequência.

Fenda submucosa do palato duroSubmucous cleft hard palate
Ponte nasal deprimidaDepressed nasal bridge
Fissura palpebral estreitaNarrow palpebral fissure
Anormalidade da cartilagem da orelha externaAbnormality of cartilage of external ear
HipocalcemiaHypocalcemia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa10
Total histórico1PubMed
Últimos 10 anos4publicações
Pico20161 papers
Linha do tempo
20202016Hoje · 2026🧪 1986Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição.

NKX2-5Homeobox protein Nkx-2.5Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Physiological factorsYAP1- and WWTR1 (TAZ)-stimulated gene expressionCardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 7, with or without atrioventricular conduction defects

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria, and atrioventricular conduction defects in some cases.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
113.8 TPM
Coração - Ventrículo esquerdo
108.3 TPM
Baço
44.1 TPM
Adipose Visceral Omentum
0.5 TPM
Testículo
0.3 TPM
OUTRAS DOENÇAS (15)
hypoplastic left heart syndrome 2tetralogy of fallotventricular septal defect 3hypothyroidism, congenital, nongoitrous, 5
HGNC:2488UniProt:P52952
GATA4Transcription factor GATA-4Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Developmental Lineage of Pancreatic Acinar CellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)Cardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 2

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Patients show other heart abnormalities including ventricular and atrioventricular septal defects, pulmonary valve thickening or insufficiency of the cardiac valves. The disease is not associated with defects in the cardiac conduction system or non-cardiac abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
144.1 TPM
Coração - Átrio
53.7 TPM
Testículo
51.1 TPM
Coração - Ventrículo esquerdo
45.2 TPM
Artéria coronária
40.7 TPM
OUTRAS DOENÇAS (12)
tetralogy of fallotventricular septal defect 1testicular anomalies with or without congenital heart diseaseatrial septal defect 2
HGNC:4173UniProt:P43694
CITED2Cbp/p300-interacting transactivator 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Regulation of gene expression by Hypoxia-inducible FactorActivation of the TFAP2 (AP-2) family of transcription factorsTFAP2 (AP-2) family regulates transcription of other transcription factorsFOXO-mediated transcription of cell death genes
MECANISMO DE DOENÇA

Ventricular septal defect 2

A common form of congenital cardiovascular anomaly that may occur alone or in combination with other cardiac malformations. It can affect any portion of the ventricular septum, resulting in abnormal communications between the two lower chambers of the heart. Classification is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect. Large defects that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death.

OUTRAS DOENÇAS (6)
ventricular septal defect 2atrial septal defect 8atrial septal defect, ostium secundum typeatrial septal defect, sinus venosus type
HGNC:1987UniProt:Q99967

Medicamentos e terapias

KETAMINEPhase 2

Mecanismo: Glutamate [NMDA] receptor negative allosteric modulator

PROPRANOLOL HYDROCHLORIDEPhase 1

Mecanismo: Beta-2 adrenergic receptor antagonist

PROPRANOLOLPhase 1

Mecanismo: Beta-1 adrenergic receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

607 variantes patogênicas registradas no ClinVar.

🧬 CITED2: NM_006079.5(CITED2):c.541AGC[3] (p.Ser183_Gly184insSer) ()
🧬 CITED2: NM_006079.5(CITED2):c.-8-11T>C ()
🧬 CITED2: NM_006079.5(CITED2):c.-8G>T ()
🧬 CITED2: NM_006079.5(CITED2):c.389C>G (p.Pro130Arg) ()
🧬 CITED2: NM_006079.5(CITED2):c.76C>G (p.His26Asp) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado2
3Fase 34
2Fase 26
1Fase 15
·Pré-clínico49
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 63 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Defeito do septo ventricular

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 26 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

63 ensaios clínicos encontrados, 13 ativos.

Distribuição por fase
NCT07623330 · Use of TEE Derived Measurement vs Direct Measurement Under G…Em breve
🇪🇬 Egito
NCT07267884 · IABP for MI-VSD Patients in SCAI SHOCK Stage BEm breve
NA🇨🇳 China
NCT07393243 · Bypass Clear Priming VSD Cardiopulmonary Bypass Circuit Redu…Em breve
NA🇺🇸 Estados Unidos
NCT04017975 · Optical Tissue Identification for Myocardial ArchitectureAtivo
PHASE2🇺🇸 Estados Unidos
NCT04034498 · A Multicenter, International, Follow-up Study to Monitor the…Ativo
🇮🇪 Irlanda · Thailand · Turkey (Türkiye) +1
NCT03363932 · French Observatory of Congenital Ventricular Septal Defect W…Ativo
🇫🇷 França
NCT07662343 · Early Warning of Structural Complications in Perimembranous …Ativo
🇨🇳 China
NCT07754591 · Comparison of Dynamic Compliance and Airway Resistance in Pr…Concluído
NA🇮🇳 Índia
NCT06298344 · The Role of Thiamine After Transcatheter Closure in Children…Concluído
EARLY_PHASE1Indonesia
NCT06214182 · Immune Heterogeneity Before and After Cardiopulmonary Bypass…Concluído
🇨🇳 China
NCT05939713 · Cera™ VSD Occluder Post Market Clinical Follow-upConcluído
🇹🇼 Taiwan
NCT05688670 · Regional Anesthesia Following Pediatric Cardiac SurgeryConcluído
PHASE4🇺🇸 Estados Unidos
NCT04452188 · Targeting Normoxia in Neonates With Cyanotic Congenital Hear…Concluído
NA🇺🇸 Estados Unidos
NCT04433520 · Trevisio Post-Approval StudyConcluído
🇫🇷 França · 🇩🇪 Alemanha · 🇮🇹 Itália +4
NCT04667455 · Improving Care for Children With Congenital Heart Disease.Concluído
NA🇸🇪 Suécia
NCT04417712 · Lifetech KONAR MFO Post-Market Clinical Follow-Up StudyConcluído
🇩🇪 Alemanha · 🇮🇹 Itália
NCT03848429 · Mechanical Complications of Acute Myocardial InfarctionConcluído
🇳🇱 Países Baixos
NCT03165526 · The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitari…Concluído
🇺🇸 Estados Unidos
NCT03684161 · Cardiopulmonary Function in Adults Born With a Ventricular S…Concluído
🇩🇰 Dinamarca
NCT05200910 · The Effect of Transcatheter VSD Closure on Children's Appeti…Concluído
Turkey (Türkiye)
NCT02914652 · The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adu…Concluído
PHASE4🇩🇰 Dinamarca
NCT02861963 · Choice of Palliative Procedures for Pulmonary Atresia With V…Concluído
NARussia
NCT04859036 · The Effect of Transcatheter Ventricular Septal Defect Closur…Concluído
Turkey (Türkiye)
NCT02552485 · Evaluation of Latent Pulmonary Arterial Hypertension in Cong…Concluído
🇧🇪 Bélgica
NCT02449083 · Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparati…Concluído
🇩🇪 Alemanha
NCT01915277 · A Phase I Study of Dexmedetomidine Bolus and Infusion in Cor…Concluído
PHASE1🇺🇸 Estados Unidos
NCT02138435 · Longterm Outcome After Ventricular Septal Defect ClosureConcluído
🇩🇰 Dinamarca
NCT02361008 · A Randomized Controlled Trial:Treatments on Infundibular Ven…Concluído
NA🇨🇳 China
NCT01228305 · Acetaminophen for Oxidative Stress After Cardiopulmonary Byp…Concluído
NA🇺🇸 Estados Unidos
NCT01480908 · Right Bundle Branch Block After Surgical Closure of Ventricu…Concluído
NA🇩🇰 Dinamarca
NCT01313832 · The Effect of Remote Ischemic Preconditioning on the Ischemi…Concluído
NASouth Korea
NCT01120964 · Intravenous L-Citrulline to Treat Children Undergoing Heart …Concluído
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT00848393 · Measures to Lower the Stress Response in Pediatric Cardiac S…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00647387 · Closure of Muscular Ventricular Septal Defects (VSDs) With t…Concluído
NA🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT00890799 · Transcatheter Closure Versus Surgery of Perimembranous Ventr…Concluído
NA
NCT00390702 · Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Co…Concluído
NA🇩🇪 Alemanha · 🇮🇱 Israel
NCT00266188 · Follow up of Post-repair Tetralogy of FallotConcluído
🇩🇪 Alemanha
NCT00556361 · Use of Ketamine Prior to Cardiopulmonary Bypass in ChildrenConcluído
PHASE2🇺🇸 Estados Unidos
NCT00199771 · Hypertonic Saline Dextran in Pediatric Cardiac SurgeryConcluído
PHASE2
NCT00583791 · Closure of Muscular Ventricular Septal Defects With The AMPL…Concluído
NA🇺🇸 Estados Unidos
NCT00005546 · Molecular Genetic Epidemiology of Three Cardiac Defects -SCO…Concluído
NCT00005322 · Molecular Genetic Epidemiology of Endocardial Cushion Defect…Concluído
NCT00000470 · Infant Heart Surgery: Central Nervous System Sequelae of Cir…Concluído
PHASE3
NCT00005190 · Reproduction and Survival After Cardiac Defect RepairConcluído
NCT06492473 · Clinical Evaluation Of Ventricular Septal Defect (VSD) In Ch…UNKNOWN
🇪🇬 Egito
NCT06320483 · Evaluation of the Effectiveness and Safety of Vibro-acoustic…UNKNOWN
Kazakhstan
NCT03941691 · A Trial to Evaluate the Safety and Efficacy of a Fully Degra…UNKNOWN
NA🇨🇳 China
NCT02644330 · Minimally Invasive Transthoracic Device Closure in Perimembr…UNKNOWN
PHASE2, PHASE3🇨🇳 China
NCT03127748 · Cardiac Function After Transcatheter VSD ClosureUNKNOWN
🇹🇼 Taiwan
NCT00006272 · Study of Energy Expenditure in Infants With Ventricular Sept…UNKNOWN
🇺🇸 Estados Unidos
NCT00173186 · Aortic Regurgitation After Surgical Repair of Outlet-Type Ve…UNKNOWN
🇹🇼 Taiwan
NCT05253209 · A Study Evaluating the Efficacy and Safety of IV L-Citrullin…Encerrado
PHASE3🇺🇸 Estados Unidos
NCT00327795 · Surgical Outcomes in Pediatric Patients With Coarctation and…Encerrado
🇺🇸 Estados Unidos
NCT00229827 · Optimal Timing for Repair of Left to Right Shunt LesionsEncerrado
🇺🇸 Estados Unidos
NCT00113698 · Angiotensin Converting Enzyme Inhibition in Children With Mi…Encerrado
PHASE3🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT07741097 · Prediction Model of Spontaneous Closure of Congenital Perime…Cancelado
🇨🇳 China
NCT01825369 · Aberrations in Carnitine Homeostasis in Congenital Heart Dis…Cancelado
PHASE1🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Arrhythmias including atrial fibrillation and congenital heart disease in Kleefstra syndrome: a possible epigenetic link.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023 Dec 28

Kleefstra syndrome (KS), often diagnosed in early childhood, is a rare genetic disorder due to haploinsufficiency of EHMT1 and is characterized by neuromuscular and intellectual developmental abnormalities. Although congenital heart disease (CHD) is common, the prevalence of arrhythmias and CHD subtypes in KS is unknown. Inspired by a novel case series of KS patients with atrial tachyarrhythmias in the USA, we evaluate the two largest known KS registries for arrhythmias and CHD: Radboudumc (50 patients) based on health record review at Radboud University Medical Center in the Netherlands and GenIDA (163 patients) based on worldwide surveys of patient families. Three KS patients (aged 17-25 years) presented with atrial tachyarrhythmias without manifest CHD. In the international KS registries, the median [interquartile range (IQR)] age was considerably younger: GenIDA/Radboudumc at 10/13.5 (12/13) years, respectively. Both registries had a 40% prevalence of cardiovascular abnormalities, the majority being CHD, including septal defects, vascular malformations, and valvular disease. Interestingly, 4 (8%) patients in the Radboudumc registry reported arrhythmias without CHD, including one atrial fibrillation (AF), two with supraventricular tachycardias, and one with non-sustained ventricular tachycardia. The GenIDA registry reported one patient with AF and another with chronic ectopic atrial tachycardia (AT). In total, atrial tachyarrhythmias were noted in six young KS patients (6/213 or 3%) with at least four (three AF and one AT) without structural heart disease. In addition to a high prevalence of CHD, evolving data reveal early-onset atrial tachyarrhythmias in young KS patients, including AF, even in the absence of structural heart disease.

#2

Congenital Heart Defects and the Risk of Spontaneous Preterm Birth.

The Journal of pediatrics2021 Feb

To estimate the association between major types of congenital heart defects (CHD) and spontaneous preterm birth, and to assess the potential underlying mechanisms. This nationwide, registry-based study included a cohort of all singleton pregnancies in Denmark from 1997 to 2013. The association between CHD and spontaneous preterm birth was estimated by multivariable Cox regression, adjusted for potential confounders. The following potential mechanisms were examined: maternal genetics (sibling analyses), polyhydramnios, preterm prelabor rupture of membranes, preeclampsia, and indicators of fetal and placental growth. The study included 1 040 474 births. Compared with the general population, CHD was associated with an increased risk of spontaneous preterm birth, adjusted hazard ratio 2.1 (95% CI, 1.9-2.4). Several subtypes were associated with increased risks, including pulmonary stenosis combined with a septal defect, 5.2 (95% CI, 3.7-7.5); pulmonary stenosis or atresia, 3.1 (95% CI, 2.4-4.1); tetralogy of Fallot 2.5 (95% CI, 1.6-3.8); coarctation or interrupted aortic arch 2.2 (95% CI, 1.5-3.2); and hypoplastic left heart syndrome, 2.0 (95% CI, 1.0-4.1). Overall, preterm prelabor rupture of membranes mediated more than one-half of the association. Maternal genetics, polyhydramnios, or indicators of fetal or placental growth did not explain the reported associations. CHD, especially right ventricular outflow tract obstructions, were associated with an increased risk of spontaneous preterm birth. The risk was carried by the CHD and not by maternal genetics. Moreover, preterm prelabor rupture of membranes was identified as a potential underlying mechanism.

#3

Prenatal diagnosis, associated findings and postnatal outcome of fetuses with double outlet right ventricle (DORV) in a single center.

Journal of perinatal medicine2019 Apr 24

Objective To assess the spectrum of associated anomalies, the intrauterine course, postnatal outcome and management of fetuses with double outlet right ventricle (DORV). Methods All cases of DORV diagnosed prenatally over a period of 8 years were retrospectively collected in a single tertiary referral center. All additional prenatal findings were assessed and correlated with the outcome. The accuracy of prenatal diagnosis was assessed. Results Forty-six cases of DORV were diagnosed prenatally. The mean gestational age at first diagnosis was 21+4 weeks (range, 13-37). A correct prenatal diagnosis of DORV was made in 96.3% of the cases. If the relation of the great arteries, the position of the ventricular septal defect (VSD) and additional cardiac anomalies are taken into account, the prenatal diagnosis was correct in 92.6% of the cases. One case was postnatally classified as transposition of the great arteries with subpulmonary VSD and was excluded from further analysis. A total of 41 (91.1%) fetuses with DORV had major additional cardiac anomalies, 30 (66.7%) had extracardiac anomalies and 13 (28.9%) had chromosomal or syndromal anomalies. Due to their complex additional anomalies, five (11.1%) of our 45 fetuses had multiple malformations and were highly suspicious for non-chromosomal genetic syndromes, although molecular diagnosis could not be provided. Disorders of laterality occurred in 10 (22.2%) fetuses. There were 17 terminations of pregnancy (37.8%), two (4.4%) intrauterine and seven (15.6%) postnatal deaths. Nineteen of 22 (86.4%) live-born children with an intention to treat were alive at last follow-up. The mean follow-up among survivors was 32 months (range, 2-72). Of 21 children who had already undergone postnatal surgery, eight (38.1%) achieved biventricular repair and 13 (61.9%) received univentricular palliation. One recently born child is still waiting for surgery. All children predicted prenatally to need a single ventricle palliation, and all children predicted to achieve biventricular repair, ultimately received the predicted type of surgery. After surgery, 14 of 18 (77.8%) children were healthy without any impairment. Conclusion DORV is a rare and often complex cardiac anomaly that can be diagnosed prenatally with high precision. DORV is frequently associated with major additional anomalies, leading to a high intrauterine and postnatal loss rate due to terminations or declined postnatal therapy. Without additional anomalies, the prognosis is good, although approximately 60% of children will have single ventricle palliation.

#4

Congenital Heart Defects and Indices of Fetal Cerebral Growth in a Nationwide Cohort of 924 422 Liveborn Infants.

Circulation2016 Feb 09

Neurodevelopmental disorders are the most common and distressful comorbidities associated with congenital heart defects (CHD). Head circumference at birth (HC), a proxy for prenatal cerebral growth, is an established risk factor for neurodevelopmental disorders. In a nationwide cohort, we included all 924 422 liveborn Danish singletons, 1997 to 2011. CHD was present in 5519. The association between CHD and growth indices was analyzed by multivariable linear regression, adjusted for potential confounders. We report mean differences in gestational age-specific z scores in comparison with the general population. CHD was associated with lower HC z scores, -0.10 (95% confidence interval [CI], -0.13 to -0.08). Several CHD subtypes were associated with smaller HC, eg, hypoplastic left heart syndrome, -0.39 (95% CI, -0.58 to -0.21); common arterial trunk, -0.41 (95% CI, -0.74 to -0.09); and major ventricular septal defects, -0.25 (95% CI, -0.35 to -0.15). Other single-ventricle defects, transposition of the great arteries, tetralogy of Fallot, and anomalous pulmonary venous return, were also associated with smaller HC. Transposition of the great arteries was associated with smaller HC relative to birth weight, -0.26 (95% CI, -0.39 to -0.13). Major ventricular septal defects were associated with larger HC relative to birth weight. The results were consistent under various conditions, eg, when siblings of infants with CHD (n=5311) or infants with other major malformations (n=24 974) were used as the reference. Several subtypes of CHD were associated with smaller HC. The associations with major ventricular septal defects, common arterial trunk, and anomalous pulmonary venous return have not previously been described. Only infants with transposition of the great arteries had smaller HC relative to birth weight.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Defeito do septo ventricular.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Defeito do septo ventricular e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma abertura na parede (septo) que separa os dois ventrículos do coração. Essa alteração pode ser congênita ou adquirida e também é chamada de comunicação inter-ventricular.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. Arrhythmias including atrial fibrillation and congenital heart disease in Kleefstra syndrome: a possible epigenetic link.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023PMID 38195854
  2. ORPHA:1480
    Orphanet
  3. Q838139
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Defeito do septo ventricular. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/defeito-do-septo-ventricular

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Defeito do septo ventricular
Compêndio · Raras BR

Defeito do septo ventricular

ORPHA:1480 · MONDO:0002070
🇧🇷 Brasil SUS
SIGTAP
5 procedimentos
Geral
CID-10
Q21.0 · Comunicação interventricular
Ensaios
13 ativos
Medicamentos
3 registrados
MedGen
UMLS
C0018818
Wikidata
Wikipedia

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara